We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+113.09%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$452M
AUM Growth
+$130M
(+40%)
Cap. Flow
-$18.5M
Cap. Flow
% of AUM
-4.08%
Top 10 Holdings %
Top 10 Hldgs %
10.66%
Holding
352
New
147
Increased
15
Reduced
84
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AWH
Aspira Women's Health Inc. Common Stock
AWH
|
+$3.03M |
| 2 |
OneSpan
OSPN
|
+$2.96M |
| 3 |
Anterix
ATEX
|
+$2.79M |
| 4 |
Calix
CALX
|
+$2.73M |
| 5 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
+$2.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Axsome Therapeutics
AXSM
|
+$3.54M |
| 2 |
Karyopharm Therapeutics
KPTI
|
+$3.44M |
| 3 |
Teladoc Health
TDOC
|
+$3.2M |
| 4 |
Krystal Biotech
KRYS
|
+$3M |
| 5 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
+$2.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.95% |
| 2 | Technology | 21.89% |
| 3 | Consumer Discretionary | 16.2% |
| 4 | Industrials | 10.05% |
| 5 | Consumer Staples | 6.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
1-800-Flowers.com
FLWS
$265M
| $1.2M | 0.26% |
+59,766
| New | +$1.18M |
|
177
AAR Corp
AIR
$5.86B
| $1.19M | 0.26% |
+57,694
| New | +$1.12M |
|
178
Allogene Therapeutics
ALLO
$673M
| $1.19M | 0.26% |
+27,685
| New | +$1M |
|
179
Ameresco
AMRC
$1.36B
| $1.18M | 0.26% |
42,327
-112,151
| -73% | -$2.26M |
|
180
Exelixis
EXEL
$14.3B
| $1.16M | 0.26% |
+48,843
| New | +$1.13M |
|
181
Cue Biopharma
CUE
$112M
| $1.14M | 0.25% |
+1,544
| New | +$1.12M |
|
|
QTS
182
DELISTED
QTS REALTY TRUST, INC.
QTS
| $1.13M | 0.25% |
17,695
-24,563
| -58% | -$1.54M |
|
183
Darden Restaurants
DRI
$23.9B
| $1.12M | 0.25% |
+14,814
| New | +$1.05M |
|
|
SWCH
184
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $1.11M | 0.24% |
+62,078
| New | +$1.09M |
|
185
Monarch Casino & Resort
MCRI
$2.18B
| $1.07M | 0.24% |
+31,322
| New | +$1.04M |
|
186
DraftKings
DKNG
$10.8B
| $1.06M | 0.23% |
+31,844
| New | +$880K |
|
|
TBHC
187
DELISTED
The Brand House Collective
TBHC
| $1.06M | 0.23% |
+390,036
| New | +$482K |
|
|
OBCI
188
DELISTED
Ocean Bio-Chem Inc
OBCI
| $1.05M | 0.23% |
+75,629
| New | +$504K |
|
|
LL
189
DELISTED
LL Flooring Holdings, Inc.
LL
| $1.04M | 0.23% |
+75,377
| New | +$639K |
|
|
ATXI
190
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
| $1.04M | 0.23% |
86
| – | – |
|
|
NIU
191
Niu Technologies
NIU
$192M
| $1.01M | 0.22% |
+63,324
| New | +$638K |
|
192
Genasys
GNSS
$78.8M
| $990K | 0.22% |
+203,762
| New | +$899K |
|
|
DRNA
193
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $990K | 0.22% |
38,983
-29,932
| -43% | -$645K |
|
|
NVMI
194
Nova
NVMI
$12.8B
| $987K | 0.22% |
20,475
-3,621
| -15% | -$154K |
|
195
Aviat Networks
AVNW
$275M
| $954K | 0.21% |
+104,580
| New | +$652K |
|
|
SILV
196
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $948K | 0.21% |
103,744
-24,893
| -19% | -$187K |
|
197
United Natural Foods
UNFI
$2.91B
| $935K | 0.21% |
+51,338
| New | +$770K |
|
|
KDMN
198
DELISTED
Kadmon Holdings, Inc.
KDMN
| $933K | 0.21% |
182,265
-214,771
| -54% | -$963K |
|
199
Broadwind
BWEN
$106M
| $931K | 0.21% |
+248,277
| New | +$560K |
|
|
BCLI
200
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $918K | 0.2% |
5,457
-3,205
| -37% | -$346K |
|
Similar funds
RWM
MCM
HP
OMG
ICCFIA
WFAL
WCM
TSS
EAM Investors's Q2 2020 Portfolio in Review
As of Q2 2020, EAM Investors held 352 positions worth $452M, up 40% from $322M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
EAM Investors withdrew a net $18.5M in Q2 2020, closing 97 positions and reducing 84 holdings. Its most notable exit was Karyopharm Therapeutics, an estimated $3.44M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 40% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, EAM Investors opened a new position in Aspira Women's Health Inc. Common Stock worth $2.61M.
- EAM Investors's largest Q2 2020 buy was Aspira Women's Health Inc. Common Stock: 45,313 shares worth $2.61M.
- EAM Investors added most to Purple Innovation in Q2 2020, an estimated $2.04M increase.
- EAM Investors's biggest Q2 2020 reduction was Axsome Therapeutics, cutting an estimated $3.54M.
- EAM Investors fully exited Karyopharm Therapeutics in Q2 2020, selling an estimated $3.44M.
- EAM Investors's ten largest holdings make up 11% of its $452M portfolio in Q2 2020.
- EAM Investors opened 147 new positions and closed 97 in Q2 2020.
- EAM Investors's portfolio value rose 40% quarter-over-quarter to $452M.
Based on EAM Investors's 13F filing for Q2 2020, filed 13 Aug 2020.